The platform strategy of using one molecule to target an underlying biological pathway to address many different diseases can ...

The Department of Health and Human Services cut funding for messenger ribonucleic acid vaccine development earlier this month.

There have been no substantial changes to the federal government’s flu vaccine recommendation: The Centers for Disease ...

Personalized vaccines are currently being investigated for the treatment of patients with kidney cancer; however, the ...

Data-driven analysis compares disease risks to vaccine risks, highlighting evidence gaps and urging review of school vaccine ...

Multiple scientists and doctors have spoken out against this decision, including infectious diseases expert Dr. Thomas A. Russo, who told Newsweek that mRNA vaccines "will be critical when the next, ...

The technology once embraced by President Donald Trump for speeding the development of COVID-19 vaccines is now under scrutiny. Health Secretary Robert F. Kennedy Jr. recently took sweeping action ...

Federal grant cuts have had a wide-ranging impact at the University of Minnesota, affecting everything from life-saving ...

CSL is laying off up to 15% of its workforce as the Australian pharma looks to cut R&D costs and spin out its vaccine ...

Following the criticism of mRNA vaccine strategies by federal leaders, UNC Health's Dr. David Wohl shared why he supports the research.

The field of viral diseases continues to pose significant challenges to global health. With the emergence of new viruses and the re-emergence of old ones, ...

Doctors and public health leaders, including at the CDC recommend that most people 6 months and older get the 2025-26 flu ...